Condition Lookup
Sub-Category:
Neurological Disorders Affecting the Throat
Number of Conditions: 5
Diphtheria affecting the throat
Specialty: Nose and Throat
Category: Throat (Pharyngeal and Laryngeal) Conditions
Sub-category: Neurological Disorders Affecting the Throat
Symptoms:
sore throat; fever; swollen lymph nodes; difficulty swallowing; pseudomembrane in the throat; difficulty breathing; hoarseness; weakness
Root Cause:
Caused by Corynebacterium diphtheriae, which produces a toxin that damages the tissues in the throat, causing a membrane to form, and potentially interfering with airway function.
How it's Diagnosed: videos
Diagnosis is made through clinical examination and confirmed by throat culture, PCR testing for the bacteria, and the presence of the characteristic pseudomembrane.
Treatment:
Antitoxin is administered to neutralize the diphtheria toxin. Antibiotics, such as penicillin or erythromycin, are used to eliminate the bacteria.
Medications:
Antitoxin (passive immunization), Penicillin (first-line antibiotic), Erythromycin (alternative antibiotic). These are classified as immunosuppressive agents (antitoxin) and antibacterial agents (penicillin, erythromycin ).
Prevalence:
How common the health condition is within a specific population.
Worldwide, but largely preventable with vaccination. More common in under-vaccinated regions, especially in developing countries.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Lack of vaccination, close contact with infected individuals, travel to endemic regions.
Prognosis:
The expected outcome or course of the condition over time.
With prompt treatment, the prognosis is good. However, untreated diphtheria can be fatal due to airway obstruction or toxin spread to other organs.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Airway obstruction, heart failure (due to myocarditis), kidney failure, nerve damage (e.g., cranial neuropathy), and death if not treated.
Spasmodic dysphonia
Specialty: Nose and Throat
Category: Throat (Pharyngeal and Laryngeal) Conditions
Sub-category: Neurological Disorders Affecting the Throat
Symptoms:
strained or strangled voice; voice breaks; difficulty with speech volume control; hoarseness; tightness or tension in the throat
Root Cause:
Dysfunction of the basal ganglia leads to abnormal muscle spasms of the laryngeal muscles, causing involuntary movements during speech.
How it's Diagnosed: videos
Diagnosis is clinical, with voice assessment by a speech-language pathologist. Laryngoscopy may show abnormal vocal cord movement during speech.
Treatment:
Botulinum toxin injections (Botox) into the laryngeal muscles to reduce spasms, speech therapy, or surgery (in severe cases).
Medications:
Botulinum toxin injections (Botox) are used to temporarily paralyze the muscles causing the spasms. It is classified as a neurotoxin, used in neurogenic conditions to reduce muscle overactivity.
Prevalence:
How common the health condition is within a specific population.
A rare condition, affecting approximately 1 in 100,000 people. It often begins in adulthood.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
May be genetic, often appearing after age 30; more common in women than men.
Prognosis:
The expected outcome or course of the condition over time.
Symptoms can be managed but not cured. With botulinum toxin injections, many patients experience improved voice quality.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic hoarseness, vocal fatigue, psychological distress due to changes in voice, difficulty with communication.
Myasthenia gravis
Specialty: Nose and Throat
Category: Throat (Pharyngeal and Laryngeal) Conditions
Sub-category: Neurological Disorders Affecting the Throat
Symptoms:
weakness in the throat muscles; difficulty swallowing; hoarseness; nasal speech; fatigue; difficulty chewing; breathing difficulty in severe cases
Root Cause:
An autoimmune disorder where the body produces antibodies against acetylcholine receptors at the neuromuscular junction, impairing muscle contraction.
How it's Diagnosed: videos
Blood tests to detect antibodies against acetylcholine receptors or anti-MuSK (muscle-specific kinase), electromyography (EMG), and the edrophonium test to assess neuromuscular junction function.
Treatment:
Acetylcholinesterase inhibitors (such as pyridostigmine), thymectomy (surgical removal of the thymus), immunosuppressive medications (steroids or other immunosuppressants), and plasmapheresis in severe cases.
Medications:
Pyridostigmine (acetylcholinesterase inhibitor), Prednisone (steroid), Azathioprine (immunosuppressant). These medications work to enhance neuromuscular transmission or suppress the autoimmune response.
Prevalence:
How common the health condition is within a specific population.
Affects approximately 1 in 5,000 people worldwide; can occur at any age but more common in women under 40 and men over 60.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Autoimmune disorders, family history, thymoma (a tumor of the thymus gland).
Prognosis:
The expected outcome or course of the condition over time.
With treatment, most patients can manage symptoms, but it is a chronic condition that requires long-term management.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Swallowing difficulties (dysphagia), respiratory failure, aspiration pneumonia, and in severe cases, myasthenic crisis (a life-threatening worsening of symptoms).
ALS with bulbar symptoms
Specialty: Nose and Throat
Category: Throat (Pharyngeal and Laryngeal) Conditions
Sub-category: Neurological Disorders Affecting the Throat
Symptoms:
difficulty speaking (dysarthria); difficulty swallowing (dysphagia); weakness in the tongue and throat muscles; hoarseness; breathing difficulties; muscle twitching; loss of motor control
Root Cause:
A neurodegenerative disease that affects motor neurons in the brain and spinal cord, leading to muscle weakness and atrophy. Bulbar onset ALS affects the brainstem, which controls swallowing and speech muscles.
How it's Diagnosed: videos
Diagnosis is clinical, confirmed with electromyography (EMG), MRI to rule out other causes, and a detailed neurological exam.
Treatment:
There is no cure for ALS, but medications like riluzole and edaravone can slow disease progression. Supportive therapies include speech therapy, physical therapy, and ventilatory support.
Medications:
Riluzole (glutamate inhibitor), Edaravone (antioxidant). These are classified as neuroprotective agents.
Prevalence:
How common the health condition is within a specific population.
Affects approximately 2 in 100,000 people; more common in individuals aged 40-70.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Genetic mutations (familial ALS), environmental factors (such as smoking and exposure to certain toxins), family history.
Prognosis:
The expected outcome or course of the condition over time.
Progressive and fatal disease, with a median survival of 2-5 years after diagnosis, depending on the progression and treatment.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Respiratory failure, aspiration pneumonia, paralysis, and loss of ability to speak or swallow.
Stroke-related dysphagia
Specialty: Nose and Throat
Category: Throat (Pharyngeal and Laryngeal) Conditions
Sub-category: Neurological Disorders Affecting the Throat
Symptoms:
difficulty swallowing; choking on food or liquids; coughing during or after eating; weight loss; hoarseness; aspiration pneumonia
Root Cause:
Damage to the brain regions involved in swallowing (such as the brainstem or cerebral cortex) due to ischemic or hemorrhagic stroke, impairing the ability to swallow properly.
How it's Diagnosed: videos
Clinical assessment, including a swallowing evaluation by a speech-language pathologist, videofluoroscopic swallow study (modified barium swallow), and endoscopic evaluation of swallowing.
Treatment:
Swallowing therapy, diet modifications (e.g., pureed food or thickened liquids), medications for aspiration pneumonia prevention, and in some cases, tube feeding.
Medications:
Proton pump inhibitors (for managing aspiration pneumonia), Antibiotics (in cases of aspiration pneumonia). These are classified as gastrointestinal protectants (PPIs) and antibacterial agents.
Prevalence:
How common the health condition is within a specific population.
Approximately 50-70% of stroke survivors experience dysphagia.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
History of stroke, particularly if the stroke affects the brainstem or areas involved in swallowing control.
Prognosis:
The expected outcome or course of the condition over time.
Dysphagia can improve with rehabilitation, but some individuals may require long-term management, including feeding tubes.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Aspiration pneumonia, dehydration, malnutrition, and increased risk of choking.